SCHEMBL13601664

SCHEMBL13601664

CN(C)CCOC(=O)CCC(=O)N1CCN(C)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.46
TSHR P16473 2/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRM3 P20309 1/20 0.40
CHRNA4 P43681 1/20 0.40
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
HPGD P15428 1/20 0.38
ACKR3 P25106 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601667 0.91 TSHR (0.42) DNM1TSHRLMNAPOLBALDH1A1
SCHEMBL12881502 0.89 GNAI3 (0.50) DNM1TSHRLMNAPOLBALDH1A1
SCHEMBL12881513 0.88 BDKRB1 (0.43) DNM1TSHRLMNAPOLBALDH1A1
SCHEMBL12881518 0.87 BDKRB1 (0.43) DNM1TSHRLMNAPOLBALDH1A1
SCHEMBL13601630 0.84 NPC1 (0.54) DNM1TSHRLMNAPOLBALDH1A1
SCHEMBL13601654 0.83 TSHR (0.51) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL13601498 0.81 DNM1 (0.49) DNM1ALDH1A1SMN1; SMN2CHRM2CHRM4
SCHEMBL12881501 0.81 GNAI3 (0.51) DNM1TSHRLMNAPOLBALDH1A1
SCHEMBL12881521 0.81 BDKRB1 (0.42) DNM1TSHRLMNAPOLBALDH1A1
SCHEMBL16015485 0.80 HTR1A (0.46) LMNAALDH1A1SMN1; SMN2HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed